FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/09/057797 [Registered on: 18/09/2023] Trial Registered Prospectively
Last Modified On: 18/09/2023
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Single Arm Study 
Public Title of Study   A single-center, Investigator Initiated study to check the Visual outcomes and Patient satisfaction after implantation of Vivity intra ocular lens in patients with mild irregular Astigmatism. 
Scientific Title of Study   A single-center, Prospective, Investigator Initiated, Observational study to evaluate the Visual outcomes and Patient satisfaction after AcrySofVivity IOL implantation in patients with mild irregular Astigmatism. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
DAE-VIOL-2023-001 version 1.0 11 Aug 2023  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ashvin Agarwal 
Designation  Executive Director and Chief of Clinical Services 
Affiliation  Dr. Agarwals Eye Hospital 
Address  Dr Agarwals Eye Hospital Limited, Clinical Research Department, Second Floor, No.222,TTK Road,Alwarpet, Chennai,Tamil Nadu,India

Chennai
TAMIL NADU
600018
India 
Phone  9840430100  
Fax    
Email  agarwal_ashvin@dragarwal.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ashvin Agarwal 
Designation  Executive Director and Chief of Clinical Services 
Affiliation  Dr. Agarwals Eye Hospital 
Address  Dr Agarwals Eye Hospital Limited, Clinical Research Department, Second Floor, No.222,TTK Road,Alwarpet, Chennai,Tamil Nadu,India


TAMIL NADU
600018
India 
Phone  9840430100  
Fax    
Email  agarwal_ashvin@dragarwal.com  
 
Details of Contact Person
Public Query
 
Name  Dr Vinod Gyanchandani 
Designation  Vice President and Head of Research 
Affiliation  Dr. Agarwals Eye Hospital 
Address  Dr Agarwals Eye Hospital Limited, Clinical Research Department, Second Floor, No.222,TTK Road,Alwarpet, Chennai,Tamil Nadu,India

Chennai
TAMIL NADU
600018
India 
Phone  9677082432  
Fax    
Email  vinod.gyanchandani@dragarwal.com  
 
Source of Monetary or Material Support  
Dr Agarwal Eye Hospital Limited 
 
Primary Sponsor  
Name  Dr Agarwal Eye Hospital Limited 
Address  Dr.Agarwal’s Eye Hospital Limited, Clinical Research Department, Second Floor, No.222,TTK Road,Alwarpet, Chennai,Tamilnadu, India Chennai TAMIL NADU 600018 India 
Type of Sponsor  Private hospital/clinic 
 
Details of Secondary Sponsor  
Name  Address 
NIL  Not Applicable 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ashvin Agarwal  Dr.Agarwals Eye Hospital  Dr.Agarwal’s Eye Hospital Limited, Clinical Research Department, Second Floor, No.222,TTK Road,Alwarpet, Chennai,Tamilnadu, India Chennai TAMIL NADU 600018 India
Chennai
TAMIL NADU 
9840430100

agarwal_ashvin@dragarwal.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Dr.Agarwal’s Eye Hospital-Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: H538||Other visual disturbances,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  None  Not Applicable 
Comparator Agent  None  Not Applicable 
 
Inclusion Criteria  
Age From  45.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  1. Adult subjects 45 years or older with the normal axial length category (22-25mm) having uncomplicated age-related cataracts and undergoing standard cataract surgery procedure.
2. The subject is willing and able to provide informed consent personally or by a legal representative.
3. Subjects with mild irregular corneal astigmatism defined as mean keratometry values not higher than 47 D, Keratoconus Index (KI) showing Superior-Inferior Asymmetry not higher than 1.4 D, and Surface Regularity Index (SRI) between 0.56 and 1.55. Magnitude of astigmatism 0.0D to <-0.75D only.
4. Central corneal thickness between 520um to 560um.
 
 
ExclusionCriteria 
Details  1. Adult subjects 45 years or older with the normal axial length category (22-25mm) having uncomplicated age-related cataracts and undergoing standard cataract surgery procedure.
2. The subject is willing and able to provide informed consent personally or by a legal representative.
3. Subjects with mild irregular corneal astigmatism defined as mean keratometry values not higher than 47 D, Keratoconus Index (KI) showing Superior-Inferior Asymmetry not higher than 1.4 D, and Surface Regularity Index (SRI) between 0.56 and 1.55. Magnitude of astigmatism 0.0D to <-0.75D only.
4. Central corneal thickness between 520um to 560um.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Monocular BCDVA postoperatively at 3 month  3 month 
 
Secondary Outcome  
Outcome  TimePoints 
1.Monocular UDVA, UIVA, UNVA postoperatively
2.Monocular DCIVA, DCNVA postoperatively

3. Spectacle independence-Patient-Reported Spectacle Independence Questionnaire (PRSIQ)
4. Patient satisfaction questionnaire (VF-14QOL)
 
3 month 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   30/09/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study aims to find if Vivity IOL can provide spherical correction for most working distances in patients with mild irregular astigmatism, thus, reducing dependency on glasses in such patients without causing significant visual disturbances.  The study shall evaluate unaided and best corrected visual acuity at different distances and patient satisfaction in patients with mild irregular astigmatism. 
Close